1392P Brigatinib in patients with ALK-positive advanced non-small cell lung cancer pretreated with sequential ALK inhibitors: A multicentric real-world study (BRIGALK study)R. Descourt,M. Pérol,D. Planchard,G. Rousseau-Bussac,B. Mennecier,M. Wislez,J. Cadranel,A.B. Cortot,F. Guisier,P. Do,R. Schott,E. Dansin,J. Arrondeau,J.B. Auliac,C. Chouaid,L. GallandAnnals of Oncology（2020）引用 2|浏览53暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
